• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.45% Nasdaq Down1.03%

    Poniard Pharmaceuticals, Inc. (PARD)

    -Other OTC
    0.15 0.00(0.00%) Jan 30, 9:30AM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2011Jun 30, 2011Mar 31, 2011Dec 31, 2010
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development287  442  333  105  
    Selling General and Administrative3,461  3,396  2,899  4,610  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (3,748) (3,838) (3,232) (4,715)
    Income from Continuing Operations
    Total Other Income/Expenses Net -  3  10  14  
    Earnings Before Interest And Taxes(3,748)(3,835)(3,222)(4,701)
    Interest Expense23  23  24  466  
    Income Before Tax(3,771)(3,858)(3,246)(5,167)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(3,771)(3,858)(3,246)(5,167)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (3,771) (3,858) (3,246) (5,167)
    Preferred Stock And Other Adjustments(48)(48)(48)(48)
    Net Income Applicable To Common Shares (3,819) (3,906) (3,294) (5,215)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.